US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ API Cuernavaca plant at Mexico with Zero observation.
Earlier, USFDA completed audit of the company’s Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, on June 16, 2017. The pharma major had been issued a Form 483 with one observation, which it is addressing.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
